SAN DIEGO, Oct. 8, 2018 /PRNewswire/ — Ansun Biopharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat severe viral infections, today announced two…
Read More
The scoop: After years operating under the radar, Ansun Biopharma (formerly NexBio) is building momentum behind a portfolio of biologic drugs for viral infections, headlined by DAS181, a first-in-class therapy in midstage...
Read More
About Us
The Dentist Team
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur lacinia nunc ac purus aliquam tincidunt. Read more..
Recent Comments